The DOI matches its Crossref record.
Malignant and Benign Neoplasms of the Thyroid in Patients Treated for Hyperthyroidism: A Report of the Cooperative Thyrotoxicosis Therapy Follow-up Study
Abstract
Data concerning the occurrence of malignant and benign thyroid neoplasms in patients treated for hyperthyroidism have been collected at 26 medical centers in the Cooperative Thyrotoxicosis Therapy Follow-up Study. There was 98.8% follow-up in 36,050 patients treated for hyperthyroidism between 1946 and 1968. The analysis is based on 34,684 patients treated by 131I, thyroidectomy, antithyroid drugs, X-irradiation or various combinations of these therapeutic measures. Cases were classified as: Graves' disease without palpable nodules, Graves' disease with palpable nodules, toxic adenoma(s) or unclassified types. The interval of time for the occurrence of a neoplasm (identified by removal) was classified as occurring either at the time of or within 1 year of initial therapy or at sometime greater than 1 yr following therapy. There were 86 malignant thyroid neoplasms found among 34,684 patients. Of those few malignant neoplasms found in Graves' disease, many were of the occult variety, the clinical potential of which is unknown. There were 9 malignant thyroid neoplasms found within 1 yr of treatment in 21,714 patients treated by 131I, 50 in 11,732 patients treated by thyroidectomy, and none in 1,238 patients treated with antithyroid drugs. After an interval of more than 1 yr there were 19 malignant thyroid neoplasms following 131I, 4 following thyroidectomy, and 4 following antithyroid therapy in these respective populations. If the occurrence of 19 malignant lesions found 1 yr or more after 131I is viewed from the standpoint of the incidental malignant lesions found in patients treated primarily by thyroidectomy, the risk from 131I is not significant. There were five anaplastic carcinomas found more than 1 yr following 131I therapy and one fibrosarcoma following thyroidectomy plus 131I therapy. The anaplastic neoplasms occurred within 5 yr of therapy and in patients with an average age of 69.4 yr. No anaplastic lesions were found within 1 yr of any treatment. There were four deaths from malignant thyroid neoplasms among 11,732 patients treated by thyroidectomy, six deaths from malignant neoplasms in 21,704 patients treated with 131I, and no deaths from malignant lesions in 1,238 patients treated more than 1 yr with antithyroid drugs. The occurrence of thyroid adenomas is higher when 131I therapy is used for treatment in the first two decades of life than when used in older individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The goal of RAI therapy for GD is to induce hypothyroidism, rather than euthyroidism, because lower administered activities of RAI result in residual, partially irradiated thyroid tissue that is at increased risk for thyroid neoplasm development (351).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [351]
Citations
Cited by
Sorted by citations
Items 101–200 of 392
(Senyurek), Y. G., Tunca, F., Harika, B., et al. (2008) · Surgery · doi:10.1016/j.surg.2008.08.022 · Cited by 44
Langsteger, W., Költringer, P., Wolf, G., et al. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90292-n · Cited by 42
Braverman, E. R., Blum, K., Loeffke, B., Baker, R. J., Kreuk, F., Yang, S. P., & Hurley, J. R. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110404158 · Cited by 39
Radioiodine I-131 for the therapy of graves' disease.
Mumtaz, M., Lin, L. S., Hui, K. C., & Khir, A. S. M. (2009) · PubMed Central · Cited by 40
Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis
Vini, L., Hyer, S. L., Pratt, B. E., & Harmer, C. (1999) · Postgraduate Medical Journal · doi:10.1136/pgmj.75.881.169 · Cited by 40
Graves' Disease: Current Concepts
McDougall, I. R. (1991) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30473-4 · Cited by 40
Balan, K. K., Raouf, A. H., & Critchley, M. (1994) · British Journal of Radiology · doi:10.1259/0007-1285-67-795-283 · Cited by 40
Berker, D. S., Işık, S., Özuğuz, U., Tütüncü, Y., Küçükler, K., Akbaba, G., Aydın, Y., & Güler, S. (2010) · Endocrine · doi:10.1007/s12020-010-9405-6 · Cited by 39
Review of the outcome of management of Graves’ disease in children and adolescents
Bergman, P., Auldist, A., & Cameron, F. (2001) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.2001.00641.x · Cited by 39
Radioiodine Treatment of Graves’ Disease in Young People
Cheetham, T. D., WRAIGHT, P. R., Hughes, I. A., & Barnes, N. D. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023183 · Cited by 38
Shahrokhian, S., Hamzehloei, A., Thaghani, A., et al. (2004) · Electroanalysis · doi:10.1002/elan.200302858 · Cited by 38
Effects of Irradiation on the Thyroid Gland
DeGroot, L. J. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30153-1 · Cited by 38
Acute and Subacute, and Riedel’s Thyroiditis
Shrestha, R. T., & Hennessey, J. V. (2015) · Europe PMC (PubMed Central) · Cited by 37
Diagnosis and Management of the Thyroid Nodule
Harvey, H. K. (1990) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(20)31293-7 · Cited by 36
Surgical Management of Graves' Disease -10-year Prospective Trial at a Single Institution-
Sugino, K., Ito, K., Nagahama, M., et al. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-013 · Cited by 35
“There are some articles suggesting that radioiodine treatment for Graves’ disease 1) increases the risk of benign thyroid nodules [11], 2) increases the risk of hyperparathyroidism [12], and 3) slightly increases the risk of more aggressive thyroid cancer [13].”
BackgroundMorimoto, I., Yoshimoto, Y., Sato, K., et al. (1987) · PubMed · Cited by 35
tsch, J. D., Rascher, W., & rr, H. G. D. (2003) · Pediatric Drugs · doi:10.2165/00128072-200305020-00003 · Cited by 35
“[30] Naturally, the latter data cannot be confirmed for the pediatric population.”
BackgroundOptions for Radionuclide Therapy: From Fixed Activity to Patient-Specific Treatment Planning
Thomas, S. R. (2002) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/10849780252824091 · Cited by 34
Khan, A. A., & Nosé, V. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1069-1_9 · Cited by 32
Medas, F., Erdas, E., Canu, G. L., et al. (2018) · Journal of Otolaryngology - Head and Neck Surgery · doi:10.1186/s40463-018-0254-2 · Cited by 32
“Furthermore, it has been reported that patients with Grave’s disease and a palpable nodule are at high risk to have a thyroid carcinoma: in these patients the incidence of thyroid carcinoma reaches 50% [12, 14, 15, 17, 25, 26].”
BackgroundIrradiation and second cancers. The thyroid as a case in point
Schlumberger, M. J., Cailleux, A.-F., Suarez, H. G., & de Vathaire, F. (1999) · Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie · doi:10.1016/s0764-4469(99)80045-6 · Cited by 32
Managing toxic thyroid adenoma: a cost-effectiveness analysis
Vidal-Trecan, G. M., Stahl, J., & Durand‐Zaleski, I. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460283 · Cited by 31
“Hypothyroidism (11, 33, 34, 36‐38) 0.185 0.064‐0.306 0.99 Recurrent hyperthyroidism (11, 31, 33‐36, 38) 0.014 0‐0.045 95 Radio-induced thyroid cancer (31, 43 , 61, 63) 0.000 (0‐0.008)”
BackgroundInfluentialPrevalence of Thyroid Cancer in Hyperthyroid Patients Treated by Surgery
Zanella, E., Rulli, F., Muzi, M. G., et al. (1998) · World Journal of Surgery · doi:10.1007/s002689900419 · Cited by 32
Late Consequences of Radioiodine for Diagnosis and Therapy in Sweden
Hall, P. N., & Holm, L. (1997) · Thyroid · doi:10.1089/thy.1997.7.205 · Cited by 32
Environmental Factors Altering Thyroid Function and Their Assessment
Barsano, C. P. (1981) · Environmental Health Perspectives · doi:10.1289/ehp.813871 · Cited by 33
Everything you wanted to know about Graves' disease
Feliciano, D. V. (1992) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)81170-5 · Cited by 31
Epidemiology of Thyroid Cancer
Schottenfeld, D., & Gershman, S. T. (1978) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.28.2.66 · Cited by 31
Melo, D. R., Brill, A. B., ZANZONICO, P. B., Vicini, P., Moroz, B. E., Kwon, D., Lamart, S., Brenner, A. V., Bouville, A. C., & Simon, S. L. (2015) · Radiation Research · doi:10.1667/rr14160.1 · Cited by 30
Tülchinsky, M., & Brill, A. B. (2019) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002792 · Cited by 29
Brill, A. B., Stabin, M. G., Bouville, A. C., & Ron, E. (2006) · Radiation Research · doi:10.1667/rr3558.1 · Cited by 29
Utiger, R. D. (1978) · New England Journal of Medicine · doi:10.1056/nejm197803232981210 · Cited by 29
Risk Factors Associated with Benign and Malignant Thyroid Nodules in Autoimmune Thyroid Diseases
Lima, P. C. M., Neto, A. M., Tambascia, M. A., et al. (2013) · ISRN Endocrinology · doi:10.1155/2013/673146 · Cited by 28
Taylor, D. M. (1981) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/bf02516104 · Cited by 28
Incidence of Thyroid Cancer in Residents Surrounding the Three Mile Island Nuclear Facility
Levin, R. J. (2008) · The Laryngoscope · doi:10.1097/mlg.0b013e3181613ad2 · Cited by 28
The history of the use of radioactive iodine
Beierwaltes, W. H. (1979) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(79)80023-9 · Cited by 28
Stocker, D. J., Foster, S. S., Solomon, B. L., et al. (2002) · Thyroid · doi:10.1089/10507250252949432 · Cited by 27
McDougall, I. R. (1992) · Springer eBooks · doi:10.1007/978-1-4899-2881-8_13 · Cited by 27
[Recommendations of the French Society of Endocrinology for the management of thyroid nodules].
Wémeau, J.-L., Sadoul, J., d’Herbomez, M., Monpeyssen, H., Tramalloni, J., Leteurtre, E., Borson‐Chazot, F., Caron, P. J., Carnaille, B. M. L., Léger, J., et al. (2011) · PubMed · Cited by 26
Thyroid Cancer And Graves’ Disease: The Controversy Ten Years Later
Mazzaferri, E. L. (2000) · Endocrine Practice · doi:10.4158/ep.6.2.221 · Cited by 26
Does Radioactive Iodine Therapy for Hyperthyroidism Cause Cancer?
Kim, B. W. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab700 · Cited by 26
Jia, Q., Li, X., Liu, Y., Li, L., Kwong, J. S. W., Ren, K., Jiang, Y. H., Sun, X., Tian, H., & Li, S. (2018) · Cancer Management and Research · doi:10.2147/cmar.s164210 · Cited by 25
Management of Graves’ Hyperthyroidism
Orgiazzi, J. (1987) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30484-5 · Cited by 24
Pathologic and Natural History
Williams, E. D. (1980) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-81325-2_5 · Cited by 25
125I Therapy in Graves' Disease
McDougall, I. R., & GREIG, W. R. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-6-720 · Cited by 25
THE DIAGNOSIS AND TREATMENT OF THYROTOXICOSIS
Irvine, W. J., & Toft, A. D. (1976) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1976.tb03872.x · Cited by 25
Radioactive Iodine: A Living History
Daniels, G. H., & Ross, D. S. (2023) · Thyroid · doi:10.1089/thy.2022.0344 · Cited by 25
“This may be particularly important for children, in whom neoplastic change may occur in nonablated remnant thyroid tissue (33,34).”
Papillary Thyroid Carcinoma and Inflammation
Fugazzola, L., Colombo, C. M., Perrino, M., et al. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00088 · Cited by 24
Lee, J., Nam, K., Chung, W. Y., Soh, E.-Y., & Park, C. S. (2008) · Journal of Korean Medical Science · doi:10.3346/jkms.2008.23.5.796 · Cited by 24
“It has been reported that the incidence of thyroid nodule in Graves’ disease patients varies from 10% to 35% (1-9).”
Reemergence of Thyroidectomy as Treatment for Graves’ Disease
Klementschitsch, P., Shen, K., & Kaplan, E. L. (1979) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)41731-7 · Cited by 24
Thyroid carcinoma after radioactive iodine therapy for Graves' disease
Ozaki, O., Ito, K., Mimura, T., Sugino, K., Kitamura, Y., Iwabuchi, H., & Kawano, M. (1994) · World Journal of Surgery · doi:10.1007/bf00353753 · Cited by 23
“Since then many authors have reported cases of thyroid carcinoma occurring after RI therapy for Graves' disease, but they have not shown a causal relation between RI therapy and the subsequent occurrence of thyroid carcinoma [ 7-9 ].”
BackgroundResultInfluentialHabra, M. A., Hijazi, R. A., Verstovsek, G., et al. (2004) · Thyroid · doi:10.1089/105072504774193249 · Cited by 23
“In another large series of 11,732 surgically treated hyperthyroid patients, there were 50 cases of thyroid carcinoma, but no cases of MTC (4).”
8 Radio-iodine treatment of hyperthyroidism— a more liberal policy?
Halnan, K. E. (1985) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(85)80043-8 · Cited by 23
Clifton, K. H., DeMott, R. K., Mulcahy, R. T., et al. (1978) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(78)90010-x · Cited by 23
Thyroid tumor risk from radiation during childhood
Silverman, C., & Hoffman, D. A. (1975) · Preventive Medicine · doi:10.1016/0091-7435(75)90075-4 · Cited by 23
Scherer, T., Wohlschläger‐Krenn, E., Bayerle‐Eder, M., Passler, C., Reiner‐Concin, A., Krebs, M., & Gessl, A. (2013) · BMC Endocrine Disorders · doi:10.1186/1472-6823-13-16 · Cited by 21
“8%) [21] compared to the general population living in a non-endemic region (5%) [22].”
BackgroundLow-Dose 131 I in Treatment of Graves' Disease
Lowdell, C. P., Spathis, G. S., Cosgrove, D. O., et al. (1985) · Journal of the Royal Society of Medicine · doi:10.1177/014107688507800305 · Cited by 22
Surgical Treatment of Graves' Disease in Children
Sugino, K., Ito, K., Mimura, T., Fukunari, N., Nagahama, M., & Ito, K. (2004) · Thyroid · doi:10.1089/105072504323150769 · Cited by 20
“There are some articles suggesting that radioiodine treat-ment for Graves’ disease (1) increases the risk of benign thyroid nodules (14); (2) increases the risk of hyperpara-thyroidism (15); and (3) slightly increases the risk of more aggressive thyroid cancer (16).”
Radioiodine for hyperthyroidism.
Franklyn, J. A., & Sheppard, M. (1992) · BMJ · doi:10.1136/bmj.305.6856.727 · Cited by 22
Nakatake, N., Fukata, S., & Tajiri, J. (2011) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2011-14 · Cited by 19
“The long-term risks of thyroid cancer appear to be lower when the thyroid gland is largely ablated than when residual thyroid tissue remains [21,22].”
BackgroundCollier, A., Ghosh, S. K., Hair, M. D., Malik, I., & McGarvie, J. (2009) · HORMONES · doi:10.14310/horm.2002.1243 · Cited by 21
“The Royal College of Physicians clinical guidelines reviewed papers studying cancer induction rates in populations following radioiodine administration and reported that increased incidence of thyroid cancer post treatment is more likely to be associated with the underlying thyroid disease than the radioiodine treatme…”
BackgroundRisk Factors for Thyroid Cancer
Nikiforov, Y. E., & Fagin, J. A. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(96)00204-4 · Cited by 21
Thyrotoxicosis and Thyroid Cancer
Yeo, P. P., Wang, K. W., Sinniah, R., et al. (1982) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1982.tb02643.x · Cited by 21
Autoimmune thyroid diseases in children
Pasala, P., & Francis, G. L. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1300525 · Cited by 22
Effect of 131I on the anemia of hyperthyroidism
Perlman, J. A., & Sternthal, P. M. (1983) · Journal of Chronic Diseases · doi:10.1016/0021-9681(83)90173-x · Cited by 20
Radioiodine for Hyperthyroidism
Cooper, D. S. (1998) · JAMA · doi:10.1001/jama.280.4.375 · Cited by 19
Treatment of juvenile Graves' disease and its ophthalmic complication: the 'European way'
Krassas, G. E. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500407 · Cited by 19
“Another consequence seems to be the increased incidence of benign thyroid adenomas ( 70 ).”
Thyroid nodules and thyroid cancer: surgical aspects.
Clark, O. H. (1980) · PubMed · Cited by 19
Radiation-Induced Thyroid Disease
Maxon, H. R. (1985) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31005-7 · Cited by 19
Radioactive Iodine Use in Childhood Graves’ Disease: Time to Wake Up and Smell the I-131
Rivkees, S. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1399 · Cited by 19
“The Cooperative Thyrotoxicosis Therapy Follow-up Study found that the incidence of thyroid carcinomas over 10–20 yr of follow-up was 5-fold higher in adults with Graves’ disease treated with thionamide drugs than in patients treated with I-131, and 8-fold higher than in patients treated surgically (12).”
BackgroundFactors Influencing the Growth of Normal and Neoplastic Thyroid Tissue
Duh, Q., & Clark, O. H. (1987) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)44184-8 · Cited by 19
Radioiodine‐associated thyroid cancers
Tezelman, S., Grossman, R. F., SIPERSTEIN, A. E., et al. (1994) · World Journal of Surgery · doi:10.1007/bf00353754 · Cited by 18
Becker, D. V. (1987) · JAMA · doi:10.1001/jama.258.5.649 · Cited by 20
Self-citationThyroid irradiation and carcinogenesis
Foster, R. S. (1975) · The American Journal of Surgery · doi:10.1016/0002-9610(75)90521-8 · Cited by 18
Onset Age is Associated with Outcome of Radioiodine Therapy in Graves' Disease
Yamashita, Y., Yamane, K., Tamura, T., et al. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.127 · Cited by 17
“Cost-effective analyses recommend ablative treatment [18, 19].”
BackgroundClinical Course of Pediatric and Adolescent Graves' Disease Treated with Radioactive Iodine
Pinto, T. E., Cummings, E. A., Barnes, D., & Salisbury, S. R. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.9.973 · Cited by 16
Gupta, K. L. (1995) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30297-0 · Cited by 17
Thyroid Irradiation — One View
Emerson, C. H., & Braverman, L. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007243030410 · Cited by 17
Moroff, S. V., & Fuks, J. Z. (1986) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950140406 · Cited by 16
Radiation-induced thyroid neoplasia
Holm, L. (1991) · Sozial- und Präventivmedizin · doi:10.1007/bf01359156 · Cited by 16
Radionuclide therapy in oncology
Clarke, S. E. (1994) · Cancer Treatment Reviews · doi:10.1016/0305-7372(94)90010-8 · Cited by 16
Stathopoulos, P., Gangidi, S., Kotrotsos, G., & Cunliffe, D. (2015) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2015.02.007 · Cited by 15
Hyperthyroïdie et cancer de la thyroïde
Daou, R. (1998) · Chirurgie · doi:10.1016/s0001-4001(99)80011-7 · Cited by 15
Hyperthyroidism with concurrent thyroid cancer.
Zanella, E., Rulli, F., Sianesi, M., et al. (2002) · PubMed · Cited by 15
The Management of Hyperthyroidism
Falk, S. A. (1990) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(20)31262-7 · Cited by 15
Clinical Management of Patients with Hyperthyroidism
Cooper, D. S., & Ridgway, E. C. (1985) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30999-3 · Cited by 15
Thyrotoxicosis in children: treatment and outcome.
Jaruratanasirikul, S., Leethanaporn, K., & Sriplung, H. (2006) · PubMed · Cited by 14
Weber, C. A., & Clark, O. H. (1985) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31008-2 · Cited by 13
Shi, H., & McHenry, C. R. (2018) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2018.07.011 · Cited by 13
Treatment of hyperthyroidism in young people
Cheetham, T. D., Hughes, I. A., Barnes, N. D., & Wraight, E. P. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.78.3.207 · Cited by 13
“Fortunately the risk of future thyroid cancer can be removed by ablating the gland and this provides a strong additional argument in favour of using this approach when treating young patients.”
BackgroundGraves' Disease that Developed Shortly after Surgery for Thyroid Cancer
Yu, H. M., Park, S. H., Lee, J. M., & Park, K. S. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.3.226 · Cited by 14
Pharmaceuticals Other Than Hormones
Habel, L. A., & FRIEDMAN, G. D. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0025 · Cited by 12
Anaplastic Thyroid Carcinoma Associated with Graves' Disease
Majima, T., Komatsu, Y., Kentaro, D. O. I., et al. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.551 · Cited by 12
Mizokami, T., Hamada, K., Maruta, T., Higashi, K., & Tajiri, J. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0468 · Cited by 12
Cancer incidence and mortality following treatment of hyperthyroidism with radioactive iodine
Evron, J. M., Esfandiari, N. H., & Papaleontiou, M. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000561 · Cited by 11
“[10], (1974) Posttreatment thyroid cancer incidence and mortality 34 684 Hyperthyroid treated with thyroidectom No statistical performed”
BackgroundRadiation-induced endocrine tumors
Schneider, A. B., & Fogelfeld, L. A. (1997) · Cancer treatment and research · doi:10.1007/978-1-4615-6355-6_7 · Cited by 12
Consequences of Thyroid Radiation in Children
Braverman, L. E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197501232920409 · Cited by 12
The diagnostic value of add-on thyroid cell block in the evaluation of thyroid lesions
Saharti, S. N. (2023) · CytoJournal · doi:10.25259/cytojournal_9_2022 · Cited by 11
“In parallel, benign thyroid nodules can be a diagnostic dilemma, such as lymphocytic/Hashimoto thyroiditis cases showing lymphoid component that mimics lymphoma.[25-28] However, the presence of classic cytologic features and flow cytometry testing can support the benign impression.”
Thyroid Carcinoma and Graves’ Disease
Cobin, R. H. (2000) · Endocrine Practice · doi:10.4158/ep.6.3.264 · Cited by 11
Radiotherapeutic agents: Properties, dosimetry, and radiobiologic considerations
Saenger, E. L., Kereiakes, J. G., Sodd, V. J., et al. (1979) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(79)80038-0 · Cited by 11
Hamburger, J. I. (1981) · Springer eBooks · doi:10.1007/978-1-4612-5916-9_3 · Cited by 11
Metadata
- Authors
- DOBYNS, B. M., SHELINE, G. E., WORKMAN, J. B., TOMPKINS, E. A., McCONAHEY, W. M., & BECKER, D. V.
- Affiliations
- MetroHealth (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1974-06
- Volume
- 38
- Issue
- 6
- Pages
- 976-998
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2047788194
- Cited by
- 391
- References
- 0
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 10 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 5 · 2015: 12 · 2014: 7 · 2013: 10 · 2012: 5
- FWCI
- 10.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Keywords
- thyroid cancer, hyperthyroidism, Graves' disease, radioiodine therapy, iodine-131, thyroidectomy, antithyroid drugs, anaplastic carcinoma, fibrosarcoma, thyroid nodules, occult thyroid cancer, radiation-induced cancer, long-term follow-up, thyroid cancer mortality
- MeSH terms
- Adenoma, Follow-Up Studies, Graves Disease, Humans, Hyperthyroidism, Iodine Radioisotopes, Antithyroid Agents, Thyroid Neoplasms, Thyroidectomy, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
